Close
Show

aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyrs Anti-NRP2 Antibody ATYR2810

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
Delivery logistics is critical to COVID-19 vaccine availability